Lacosamide Medley (Lacosamide)

Lacosamide is an anticonvulsant that targets neuronal hyperexcitability in focal seizure disorders.

• Partial-onset seizures: reduces seizure frequency and severity in patients with focal epilepsy.
• Epilepsy (focal): provides adjunctive control of seizures when used with other antiepileptic drugs.
• Refractory focal epilepsy: may be added to improve seizure management in patients not responding to first‑line therapy.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing repetitive neuronal firing. By selectively targeting the slow inactivation phase, it reduces neuronal hyperexcitability without affecting normal rapid channel activity, contributing to seizure control in focal epilepsy.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dizziness: sensation of light‑headedness or imbalance.
• Nausea: mild to moderate stomach upset.
• Headache: tension‑type or throbbing pain.
• Fatigue: unusual tiredness or lack of energy.
• Blurred vision: temporary visual disturbances.
• Diplopia: double vision episodes.

Serious or Rare Side Effects

• Suicidal ideation: thoughts of self‑harm requiring immediate evaluation.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Cardiac arrhythmia: abnormal heart rhythms, especially PR‑interval prolongation.
• Respiratory depression: slowed breathing in vulnerable patients.
• Anaphylaxis: acute allergic reaction with airway compromise.
• Liver injury: elevated hepatic enzymes or hepatitis.

Before initiating Lacosamide therapy, consider the following safety measures.

• Renal impairment: assess kidney function and adjust dose if necessary.
• Hepatic impairment: monitor liver enzymes and consider dose modification.
• Cardiac conduction: obtain baseline ECG and monitor for PR‑interval changes.
• Pregnancy: risk unknown; discuss potential benefits and risks with a healthcare professional.
• Driving and operating machinery: caution advised due to possible dizziness or visual changes.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase lacosamide plasma levels.
• Strong CYP3A4 inducers (e.g., carbamazepine): may reduce lacosamide effectiveness.
• Other sodium‑channel blockers (e.g., phenytoin): heightened risk of CNS depression.

Moderate Interactions (Monitor Closely)

• Alcohol: may exacerbate dizziness and sedation.
• Other antiepileptics (e.g., valproate): monitor for additive side effects.
• Antihypertensives: possible additive hypotensive effect.
• Oral contraceptives: may reduce hormonal efficacy.
• Serotonergic agents: watch for serotonin syndrome signs.